Related Experiment Videos
Post-stent management with a pneumatic groin compression device and self injected low molecular weight heparin
1Department of Invasive Cardiology, Royal Brompton Hospital, London.
Insights
A simplified post-coronary stent protocol using pneumatic compression and low molecular weight heparin (LMWH) reduced complications and hospital stays. This approach offers an effective alternative for managing patients after stent implantation.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Coronary stent implantation benefits are limited by arterial puncture site complications and extended hospital stays.
- Systemic anticoagulation is often perceived as necessary post-stent, contributing to patient morbidity.
Purpose of the Study:
- To evaluate a simplified post-stent management protocol.
- The protocol utilizes the Femostop pneumatic compression device and subcutaneous low molecular weight heparin (LMWH).
Main Methods:
- A case series of 100 consecutive patients with stable angina undergoing coronary stenting.
- Patients were managed with the Femostop device and LMWH for post-procedural care.
- Data collected included complication rates and hospital length of stay.
Main Results:
- 92% of patients experienced an uncomplicated clinical course.
- 44% of patients were discharged on post-procedural day 1, and 48% on day 2.
- The overall rate of vascular or bleeding complications was 6%.
Conclusions:
- Subcutaneous LMWH offers a practical and effective alternative to intravenous heparin for systemic anticoagulation post-stent.
- This simplified protocol may reduce morbidity and shorten hospital stays for patients undergoing coronary stenting.
Background:
The benefits of intracoronary stent implantation are offset by an increased risk of complications at the arterial puncture site and a prolonged hospital stay. Much of this morbidity can be attributed to the generally perceived need to achieve systemic anticoagulation after stent implantation.
Aim:
To test a simplified protocol for post-stent management using the Femostop pneumatic groin compression device and low molecular weight (fractionated) heparin (LMWH) administered by subcutaneous injection.
Patients:
A case series of 100 consecutive patients, with stable angina pectoris, undergoing coronary stenting for a suboptimal result after conventional balloon angioplasty.
Methods:
All patients were managed with a new post-stent protocol using the Femostop pneumatic groin compression device and LMWH. The incidence of complications and the length of hospital stay were recorded.
Results:
The clinical course was uncomplicated in 92 patients and their discharge from hospital was achieved on the first post-procedural day for 44 patients and on the second for the remaining 48. The rate of vascular or bleeding complications was 6%.
Conclusions:
LMWH administered by subcutaneous injection may provide a practical and effective alternative to the use of intravenous heparin when systemic anticoagulation is used after stent implantation.